CONSTELLATION PHARMCETICLS I's ticker is CNST and the CUSIP is 210373106. A total of 136 filers reported holding CONSTELLATION PHARMCETICLS I in Q1 2021. The put-call ratio across all filers is 1.43 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $4,047,000 | +57.8% | 119,720 | +9.1% | 0.00% | 0.0% |
| Q1 2021 | $2,565,000 | -19.9% | 109,689 | -1.3% | 0.00% | 0.0% |
| Q4 2020 | $3,201,000 | +49.4% | 111,130 | +5.0% | 0.00% | 0.0% |
| Q3 2020 | $2,143,000 | -26.6% | 105,806 | +8.9% | 0.00% | 0.0% |
| Q2 2020 | $2,919,000 | +51.9% | 97,145 | +58.8% | 0.00% | 0.0% |
| Q1 2020 | $1,922,000 | -20.2% | 61,165 | +19.7% | 0.00% | 0.0% |
| Q4 2019 | $2,408,000 | +1025.2% | 51,116 | +54.3% | 0.00% | – |
| Q3 2019 | $214,000 | -52.0% | 33,131 | -8.8% | 0.00% | – |
| Q2 2019 | $446,000 | -13.7% | 36,330 | -4.9% | 0.00% | – |
| Q1 2019 | $517,000 | – | 38,210 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ponoi II Management, LLC | 1,574,229 | $36,821,000 | 28.20% |
| Ponoi Management, LLC | 1,880,623 | $43,988,000 | 25.87% |
| VR Adviser, LLC | 4,016,873 | $93,955,000 | 10.19% |
| Column Group LLC | 2,626,631 | $61,437,000 | 5.89% |
| Euclidean Capital LLC | 554,325 | $12,966,000 | 4.34% |
| GREAT POINT PARTNERS LLC | 872,415 | $20,406,000 | 4.22% |
| Venrock Management V, LLC | 1,570,058 | $36,724,000 | 3.76% |
| COMMODORE CAPITAL LP | 368,448 | $8,618,000 | 3.43% |
| REGENTS OF THE UNIVERSITY OF CALIFORNIA | 621,541 | $14,538,000 | 1.90% |
| Bain Capital Life Sciences Investors, LLC | 1,400,000 | $32,746,000 | 1.86% |